MNKD
Price
$5.54
Change
+$0.21 (+3.94%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.64B
46 days until earnings call
OTLC
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
31.87M
59 days until earnings call
Interact to see
Advertisement

MNKD vs OTLC

Header iconMNKD vs OTLC Comparison
Open Charts MNKD vs OTLCBanner chart's image
MannKind
Price$5.54
Change+$0.21 (+3.94%)
Volume$483.77K
Capitalization1.64B
Oncotelic Therapeutics
Price$0.07
Change-$0.00 (-0.00%)
Volume$195.95K
Capitalization31.87M
MNKD vs OTLC Comparison Chart in %
Loading...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MNKD vs. OTLC commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNKD is a Buy and OTLC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (MNKD: $5.33 vs. OTLC: $0.07)
Brand notoriety: MNKD and OTLC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNKD: 104% vs. OTLC: 129%
Market capitalization -- MNKD: $1.64B vs. OTLC: $31.87M
MNKD [@Biotechnology] is valued at $1.64B. OTLC’s [@Biotechnology] market capitalization is $31.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNKD’s FA Score shows that 0 FA rating(s) are green whileOTLC’s FA Score has 0 green FA rating(s).

  • MNKD’s FA Score: 0 green, 5 red.
  • OTLC’s FA Score: 0 green, 5 red.
According to our system of comparison, MNKD is a better buy in the long-term than OTLC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNKD’s TA Score shows that 4 TA indicator(s) are bullish while OTLC’s TA Score has 6 bullish TA indicator(s).

  • MNKD’s TA Score: 4 bullish, 5 bearish.
  • OTLC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, OTLC is a better buy in the short-term than MNKD.

Price Growth

MNKD (@Biotechnology) experienced а -4.99% price change this week, while OTLC (@Biotechnology) price change was +7.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Reported Earning Dates

MNKD is expected to report earnings on Nov 11, 2025.

OTLC is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.64B) has a higher market cap than OTLC($31.9M). OTLC YTD gains are higher at: 109.371 vs. MNKD (-17.107). MNKD has higher annual earnings (EBITDA): 79.1M vs. OTLC (-3.36M). MNKD has more cash in the bank: 179M vs. OTLC (88K). OTLC has less debt than MNKD: OTLC (13.5M) vs MNKD (46.8M). MNKD has higher revenues than OTLC: MNKD (302M) vs OTLC (0).
MNKDOTLCMNKD / OTLC
Capitalization1.64B31.9M5,125%
EBITDA79.1M-3.36M-2,353%
Gain YTD-17.107109.371-16%
P/E Ratio48.45N/A-
Revenue302M0-
Total Cash179M88K203,409%
Total Debt46.8M13.5M347%
FUNDAMENTALS RATINGS
MNKD vs OTLC: Fundamental Ratings
MNKD
OTLC
OUTLOOK RATING
1..100
7723
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
48100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
4137
P/E GROWTH RATING
1..100
9794
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OTLC's Valuation (52) in the null industry is in the same range as MNKD (53) in the Biotechnology industry. This means that OTLC’s stock grew similarly to MNKD’s over the last 12 months.

MNKD's Profit vs Risk Rating (48) in the Biotechnology industry is somewhat better than the same rating for OTLC (100) in the null industry. This means that MNKD’s stock grew somewhat faster than OTLC’s over the last 12 months.

OTLC's SMR Rating (97) in the null industry is in the same range as MNKD (100) in the Biotechnology industry. This means that OTLC’s stock grew similarly to MNKD’s over the last 12 months.

OTLC's Price Growth Rating (37) in the null industry is in the same range as MNKD (41) in the Biotechnology industry. This means that OTLC’s stock grew similarly to MNKD’s over the last 12 months.

OTLC's P/E Growth Rating (94) in the null industry is in the same range as MNKD (97) in the Biotechnology industry. This means that OTLC’s stock grew similarly to MNKD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MNKDOTLC
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WMMAX16.47N/A
N/A
TETON Westwood Mighty Mites A
LADPX22.97N/A
N/A
Lord Abbett Developing Growth P
JMCGX29.36N/A
N/A
Jacob Discovery Fd Inv
VCGRX23.91N/A
N/A
Virtus KAR Capital Growth R6
FSCSX28.98N/A
N/A
Fidelity Select Software & IT Svcs Port

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with IONS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
N/A
IONS - MNKD
46%
Loosely correlated
-1.52%
CYTK - MNKD
45%
Loosely correlated
-0.95%
VCYT - MNKD
44%
Loosely correlated
+0.43%
LXRX - MNKD
42%
Loosely correlated
+0.75%
INSM - MNKD
40%
Loosely correlated
-3.84%
More

OTLC and

Correlation & Price change

A.I.dvisor tells us that OTLC and TENX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLC and TENX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLC
1D Price
Change %
OTLC100%
+3.43%
TENX - OTLC
23%
Poorly correlated
+4.77%
MNKD - OTLC
22%
Poorly correlated
N/A
IMTX - OTLC
21%
Poorly correlated
-3.82%
MMIRF - OTLC
15%
Poorly correlated
N/A
IPHYF - OTLC
4%
Poorly correlated
N/A
More